Dr. Darius Mohammad Moshfeghi, MD

Dr. Moshfeghi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Moshfeghi's NPI, 1386702819, was assigned on December 5, 2006. Dr. Moshfeghi graduated from Tulane School of Medicine in 1995. Dr. Moshfeghi holds California license A78163.

Dr. Moshfeghi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Moshfeghi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Moshfeghi to 1 more hospital, 5 medical groups and 2 group practices and clinics, each named with a free account. Dr. Moshfeghi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moshfeghi practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Moshfeghi's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Moshfeghi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Moshfeghi's licenses on file in 15 states: California, Arizona, Colorado, Florida, Iowa, Idaho, Michigan, New Hampshire, New Mexico, Nevada, Tennessee, Washington, West Virginia, Alaska and Georgia.

Dmand AI lists age-related macular degeneration, cataract, inflammation of iris, retinal detachment, retinal occlusion, secondary membranaous cataract surgery, visual impairment and blindness and vitreous eye degeneration among the conditions Dr. Moshfeghi treats.

CMS data shows 1,387 Medicare services from Dr. Moshfeghi across 4 procedure codes in 2024, for 319 Medicare patients. Medicare paid $79,894 for them. Every service was in an office.

CMS counts 319 Medicare patients who saw Dr. Moshfeghi in 2024. The largest group is 75 to 84, with 119 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moshfeghi's median patient age at 22, with 46% women.

In 2024, Dr. Moshfeghi wrote 20 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $541 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Moshfeghi for performance year 2024, reported as part of a group. Dr. Moshfeghi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 208 papers to Dr. Moshfeghi, published from 2007 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Retinopathy of Prematurity, Visual Acuity and Fluorescein Angiography. Dr. Moshfeghi has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Moshfeghi's most frequent co-authors are Natalia Fijalkowski Callaway, MD, Daniel Garrett Vail, MD and Marco H. Ji, MD.

Dmand AI links Dr. Moshfeghi to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Retinopathy of Prematurity and Infant, Premature, Diseases. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Moshfeghi that name 2 trials.

CMS Open Payments shows 172 general payments to Dr. Moshfeghi from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Alexion Pharmaceuticals, Inc. paid the most, $575,875. It also lists 34 research payments totaling $154,746 from 2016 to 2025, naming 2 clinical trials.

Dmand AI lists 3 awards for Dr. Moshfeghi, most recently Regional Top Doctor in 2014.

Dr. Moshfeghi graduated from Tulane School of Medicine in 1995. Dr. Moshfeghi is a member of AAO.

Dr. Moshfeghi is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.